173 related articles for article (PubMed ID: 37445830)
1. CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway.
Liu W; Wang L; Zhang J; Cheng K; Zheng W; Ma Z
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445830
[TBL] [Abstract][Full Text] [Related]
2. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
3. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
4. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
Jiang XL; Gao JC; Jiang L; Zhang PX; Kang TJ; Sun Q; Qi WJ; Zhang QP; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):541-547. PubMed ID: 31461811
[No Abstract] [Full Text] [Related]
6. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase.
Lin SK; Kok SH; Shun CT; Hong CY; Wang CC; Hsu MC; Liu CM
Am J Rhinol; 2007; 21(2):251-5. PubMed ID: 17424890
[TBL] [Abstract][Full Text] [Related]
8. Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling.
Zhao J; Klausen C; Yi Y; Cheng JC; Chang HM; Leung PCK
Cell Signal; 2020 Jan; 65():109439. PubMed ID: 31654720
[TBL] [Abstract][Full Text] [Related]
9. SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling.
Bao F; An S; Yang Y; Xu TR
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107587
[TBL] [Abstract][Full Text] [Related]
10. CC-Chemokine Ligand 2 (CCL2) Suppresses High Density Lipoprotein (HDL) Internalization and Cholesterol Efflux via CC-Chemokine Receptor 2 (CCR2) Induction and p42/44 Mitogen-activated Protein Kinase (MAPK) Activation in Human Endothelial Cells.
Sun RL; Huang CX; Bao JL; Jiang JY; Zhang B; Zhou SX; Cai WB; Wang H; Wang JF; Zhang YL
J Biol Chem; 2016 Sep; 291(37):19532-44. PubMed ID: 27458015
[TBL] [Abstract][Full Text] [Related]
11. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
[TBL] [Abstract][Full Text] [Related]
12. ERK activation and nuclear signaling induced by the loss of cell/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells.
Al-Ayoubi A; Tarcsafalvi A; Zheng H; Sakati W; Eblen ST
J Cell Biochem; 2008 Oct; 105(3):875-84. PubMed ID: 18726893
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits.
Jiménez-Sainz MC; Murga C; Kavelaars A; Jurado-Pueyo M; Krakstad BF; Heijnen CJ; Mayor F; Aragay AM
Mol Biol Cell; 2006 Jan; 17(1):25-31. PubMed ID: 16221891
[TBL] [Abstract][Full Text] [Related]
14. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
Wuyts WA; Vanaudenaerde BM; Dupont LJ; Demedts MG; Verleden GM
Respir Med; 2003 Jul; 97(7):811-7. PubMed ID: 12854631
[TBL] [Abstract][Full Text] [Related]
15. Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.
Bauer D; Redmon N; Mazzio E; Taka E; Reuben JS; Day A; Sadrud-Din S; Flores-Rozas H; Soliman KF; Darling-Reed S
Cytokine; 2015 Sep; 75(1):117-26. PubMed ID: 26100848
[TBL] [Abstract][Full Text] [Related]
16. CCL2 overexpression is associated with paclitaxel resistance in ovarian cancer cells via autocrine signaling and macrophage recruitment.
Yang YI; Wang YY; Ahn JH; Kim BH; Choi JH
Biomed Pharmacother; 2022 Sep; 153():113474. PubMed ID: 36076499
[TBL] [Abstract][Full Text] [Related]
17. C-C motif chemokine ligand 2 induces proliferation and prevents lipopolysaccharide-induced inflammatory responses in bovine mammary epithelial cells.
Yang C; Lim W; Bae H; Bazer FW; Song G
J Dairy Sci; 2018 May; 101(5):4527-4541. PubMed ID: 29454702
[TBL] [Abstract][Full Text] [Related]
18. Expression and purification of recombinant human CCL5 and its biological characterization.
Ma Z; Zhang J; Wang L; Liu Y; Wang Y; Liu W; Xing G; Cheng K; Zheng W; Xiang L
Protein J; 2022 Apr; 41(2):337-344. PubMed ID: 35524873
[TBL] [Abstract][Full Text] [Related]
19. NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP.
Wen Y; Fan L; Pang L; Zhao T; Li R; Zhang Y; Zhang L; Yang W
Gynecol Endocrinol; 2022 Dec; 38(12):1136-1146. PubMed ID: 36592742
[TBL] [Abstract][Full Text] [Related]
20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
